HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mary T Litzinger Selected Research

CD58 Antigens (LFA-3)

10/2010Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells.
6/2009Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mary T Litzinger Research Topics

Disease

5Neoplasms (Cancer)
05/2014 - 10/2010
3Carcinoma (Carcinomatosis)
05/2014 - 05/2011
2Neoplasm Metastasis (Metastasis)
05/2014 - 10/2013
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2010 - 06/2009
1Breast Neoplasms (Breast Cancer)
05/2014
1Vaccinia
06/2009
1Infections
06/2009

Drug/Important Bio-Agent (IBA)

4Brachyury protein (Brachyury)IBA
05/2014 - 05/2011
3VaccinesIBA
05/2014 - 10/2010
2Transcription Factors (Transcription Factor)IBA
05/2014 - 10/2013
2Cancer VaccinesIBA
06/2012 - 05/2011
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2010 - 06/2009
2CD58 Antigens (LFA-3)IBA
10/2010 - 06/2009
2AntigensIBA
10/2010 - 06/2009
1Proteins (Proteins, Gene)FDA Link
05/2014
1Docetaxel (Taxotere)FDA Link
05/2014
1Messenger RNA (mRNA)IBA
05/2014
1TamoxifenFDA LinkGeneric
05/2014
1Neoplasm Antigens (Tumor Antigens)IBA
05/2011
1CD40 Ligand (CD40L)IBA
10/2010

Therapy/Procedure

4Therapeutics
05/2014 - 05/2011
3Drug Therapy (Chemotherapy)
10/2013 - 05/2011
1Immunotherapy
10/2010